Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Dallas, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies, today announced its financial results for the three and six ...
Across the first two days of August, the S&P 500 ( ^GSPC) slid 3.2% while the Nasdaq Composite ( ^IXIC) sank 4.7%. The moves extended a previous drawdown in the Nasdaq, with the index entering a ...
LAS VEGAS, NV, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc. (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, today announced that Chief Executive Officer Brian Goodman will be participating in a live interview with Benzinga Executive Producer Zunaid Suleman this Wednesday, August 21st, on Benzinga All-Access at approximately 11:40 a ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.